Effective March 1, 2022, healthcare providers will have to obtain prior approval to administer three specific injections. The following medications are used in cancer treatment and now require prior authorization:
| Name of the drug | Procedure code |
| Belrapzo | J9036 |
| Sarclisa | J9227 |
| Khapzory | J0642 |
Unauthorized services performed on or after March 1, 2022, will be denied. You can obtain prior approval on the
Availity provider portal.
Source:
https://mediprovider.empireblue.com
Discover more from Doctor Trusted
Subscribe to get the latest posts sent to your email.
